The Procedure for Conducting Courier Service Activities in the field of E-commerce has been approved

On July 18, 2025, by order of the Director of the National Agency for Advanced Projects
No. 3631, the Regulation on the Procedure for Carrying out Courier Service Activities in E-commerce (hereinafter referred to as the "Regulation") was approved. The document was adopted in accordance with the Law on E-Commerce and the Resolution of the Cabinet of Ministers of the Republic of Uzbekistan on Measures for the Further Development of the E-Commerce Sector in the Republic of Uzbekistan dated December 26, 2024, No. 885, which highlights the priority of digitalizing trade and enhancing e-commerce standards in the Republic of Uzbekistan. The Regulation mainly focuses on issues of transparency, safety, and adherence to sanitary standards in goods’ delivery, especially concerning the transportation of food products.

Amendments to the List of Medicines Subject to Price Regulation for Wholesale and Retail Sale

By Order of the Minister of Health of the Republic of Kazakhstan dated June 18, 2025 No. 394 ("Order No. 394"), amendments were made to the List of Medicines Subject to Price Regulation for Wholesale and Retail Sale approved by Order of the Acting Minister of Health of the Republic of Kazakhstan dated December 1, 2022 No. KR DSM-150.

In accordance with the amendments, the number of medicines on the List Subject to Price Regulation for Wholesale and Retail Sale has been reduced from 6,060 to 5,408. Over-the-counter Medicines have been excluded from the list. Order No. 394 came into force on July 5, 2025.

Overview of Key Amendments to the Regulation of Medicine Prices in Uzbekistan

On 12 May 2025, the Minister of Health of the Republic of Uzbekistan (the “Uzbekistan”) issued the Order “On Amendments and Additions to the Order ‘On Approval of the Regulation on the Procedure for Accounting Medicine Prices within the Reference Pricing System’” No. Order-3242–1 dated 12 May 2025 (the “Order No. 3242–1”).

Below is an overview of the key changes introduced to the regulation of the reference pricing for prescription medicines as set forth in the Order No. 3242–1.

New Initiatives for the Development of the Pharmaceutical Industry in the Republic of Uzbekistan

On January 28, 2025, the President of the Republic of Uzbekistan (“Uzbekistan”) signed the Decree “On Additional Measures for the Accelerated Development of the Pharmaceutical Industry” No. UP-13 (the “Decree No. 13”), which came into force on January 29, 2025.

Below is an overview of the key regulatory changes in the pharmaceutical industry introduced by the Decree No. 13. The most significant amendments include the abolition of price markup limitations on over-the-counter medicines and the imposition of a 2% customs duty on certain categories of medicines, effective April 1, 2025.

The Law "On Telecommunications" has been adopted in a new edition

On December 27, 2024, the President of the Republic of Uzbekistan, Shavkat Mirziyoyev, signed the Law "On Telecommunications" No. LRU-1015 (the "Telecommunication Law"), which came into force on December 28, 2024. With the adoption of the new edition of the Telecommunication Law, the previous version, dated August 20, 1999, was repealed.

On December 27, 2024, in pursuance of the Roadmap for the Elimination of Corruption Risks identified in the operation of SK-Pharmacy LLP and the Action Plan approved based on the results of the audit by the Supreme Audit Chamber, the Minister of Health of the Republic of Kazakhstan issued the Order No. 112 (the "Order No. 112"), which introduced amendments and additions to the Order No. 110 dated June 7, 2023 (the "Order No. 110") "On the Approval of the Rules for the Organization and Implementation of the Procurement of Medicines, Medical Devices, and Specialized Therapeutic Products within the Framework of the Guaranteed Volume of Free Medical Care, Additional Volume of Medical Assistance for Persons Held in Pre-Trial Detention Centers and Facilities of the Penal (Penitentiary) System, at the Expense of Budgetary Funds and/or within the Compulsory Social Medical Insurance System, as well as Pharmaceutical Services" (the "Rules").

New Initiatives for the Advancement of E-Commerce in Uzbekistan

On December 26, 2024, the Cabinet of Ministers of the Republic of Uzbekistan (“Uzbekistan”) adopted Resolution No. 885 "On Measures for the Further Development with the sphere
E-Commerce in the Republic of Uzbekistan" (the "Regulation No. 885"). Below is an overview of the key regulatory innovations in e-commerce introduced by the Regulation No. 885.

Kazakhstan – December 2024

By the Order of the Minister of Health of the Republic of Kazakhstan (“RK”) dated December 25, 2024 No. 110 (the “Order No. 110”) amendments have been made to the Rules for Regulation, Formation of Maximum Prices and Markups for Medicines as well as Medical Devices (“MD”) within the Framework of the Guaranteed Volume of Free Medical Care (“GVFMC”) and/or in the Obligatory Social Medical Insurance System (“OSMI”) approved by the Order of the Minister of Health of the RK dated December 11, 2020 No. ҚР ДСМ-247/2020 (the “Rules”).

New Measures for Improving the Supply of Pharmaceuticals and Medical Equipment to State Medical Facilities in Uzbekistan

On November 29, 2024, the President of the Republic of Uzbekistan issued Resolution  
No. PR-408 “On Measures to Improve the Supply of Pharmaceuticals and Medical Equipment System for Medical Facilities” (“Resolution  No. 408”).

Regulation on conducting post-marketing surveillance of pharmaceutical products has been approved.

On October 4, 2024, the Cabinet of Ministers of the Republic of Uzbekistan adopted Resolution No. 628, titled "On the approval of the Regulation on the Procedure for Conducting Post-marketing Surveillance of Pharmaceutical Products" (the "Regulation No. 628"), which came into effect on October 5, 2024.

According to Regulation No. 628, post-marketing surveillance is conducted by the Pharmaceutical Product Safety Center under the Ministry of Health of the Republic of Uzbekistan (the “Center”) without interfering in the financial and economic activities of business entities."